Filing Flows › Caris Life Sciences (CAI) › Molecular Profiling Services revenue
Caris Life Sciences (CAI) Molecular Profiling Services revenue by quarter
Caris Life Sciences' Molecular Profiling Services revenue was $263M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 6 quarters it ranged from $163M (Q2 2025) to $282M (Q4 2025).
| Quarter | Molecular Profiling Services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $263M | +4% | +27% |
| Q2 2026 | $252M | +20% | +55% |
| Q1 2026 | $211M | -25% | — |
| Q4 2025 | $282M | +36% | — |
| Q3 2025 | $208M | +27% | — |
| Q2 2025 | $163M | — | — |
Q3 2026 at a glance
Caris Life Sciences, Q3 2026: revenue $275M (+27% year over year), operating margin 7.0%, net earnings $15.2M, operating cash flow −$22.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Caris Life Sciences' Molecular Profiling Services revenue?
Caris Life Sciences' Molecular Profiling Services revenue was $263M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Caris Life Sciences' Molecular Profiling Services revenue changed?
Over the last 6 quarters it ranged from $163M (Q2 2025) to $282M (Q4 2025).